Literature DB >> 18338391

Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa.

Abdul-Rauf Sayed1, David Bourne, Robert Pattinson, Jo Nixon, Bertram Henderson.   

Abstract

BACKGROUND: In October 2003 South Africa embarked on a program of folic acid fortification of staple foods. We measured the change in prevalence of NTDs before and after fortification and assessed the cost benefit of this primary health care intervention.
METHODS: Since the beginning of 2002 an ecological study was conducted among 12 public hospitals in four provinces of South Africa. NTDs as well as other birth defect rates were reported before and after fortification. Mortality data were also collected from two independent sources.
RESULTS: This study shows a significant decline in the prevalence of NTDs following folic acid fortification in South Africa. A decline of 30.5% was observed, from 1.41 to 0.98 per 1,000 births (RR = 0.69; 95% CI: 0.49-0.98; p = .0379). The cost benefit ratio in averting NTDs was 46 to 1. Spina bifida showed a significant decline of 41.6% compared to 10.9% for anencephaly. Additionally, oro-facial clefts showed no significant decline (5.7%). An independent perinatal mortality surveillance system also shows a significant decline (65.9%) in NTD perinatal deaths, and in NTD infant mortality (38.8%).
CONCLUSIONS: The decrease in NTD rates postfortification is consistent with decreases observed in other countries that have fortified their food supplies. This is the first time this has been observed in a predominantly African population. The economic benefit flowing from the prevention of NTDs greatly exceeds the costs of implementing folic acid fortification. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18338391     DOI: 10.1002/bdra.20442

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  65 in total

1.  Roles of genetic counselors in South Africa.

Authors:  Jennifer G R Kromberg; Tina-Marié Wessels; Amanda Krause
Journal:  J Genet Couns       Date:  2013-05-31       Impact factor: 2.537

Review 2.  Prevention of myelomeningocele: African perspectives.

Authors:  Taopheeq Bamidele Rabiu; Amos Olufemi Adeleye
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

3.  Folate bioavailability: implications for establishing dietary recommendations and optimizing status.

Authors:  Marie A Caudill
Journal:  Am J Clin Nutr       Date:  2010-03-10       Impact factor: 7.045

4.  Modelled epidemiological data for selected congenital disorders in South Africa.

Authors:  Helen L Malherbe; Colleen Aldous; Arnold L Christianson; Matthew W Darlison; Bernadette Modell
Journal:  J Community Genet       Date:  2021-03-05

Review 5.  Insights into metabolic mechanisms underlying folate-responsive neural tube defects: a minireview.

Authors:  Anna E Beaudin; Patrick J Stover
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-04

Review 6.  Folic acid to reduce neonatal mortality from neural tube disorders.

Authors:  Hannah Blencowe; Simon Cousens; Bernadette Modell; Joy Lawn
Journal:  Int J Epidemiol       Date:  2010-04       Impact factor: 7.196

7.  Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia.

Authors:  Christine Manyando; Rhoda Mkandawire; Lwipa Puma; Moses Sinkala; Evans Mpabalwani; Eric Njunju; Melba Gomes; Isabela Ribeiro; Verena Walter; Mailis Virtanen; Raymond Schlienger; Marc Cousin; Miriam Chipimo; Frank M Sullivan
Journal:  Malar J       Date:  2010-09-01       Impact factor: 2.979

8.  Folic acid supplementation use and the MTHFR C677T polymorphism in orofacial clefts etiology: An individual participant data pooled-analysis.

Authors:  Azeez Butali; Julian Little; Cécile Chevrier; Sylvian Cordier; Regine Steegers-Theunissen; Astanand Jugessur; Bola Oladugba; Peter A Mossey
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2013-05-13

9.  Central nervous system congenital malformations in a developing country: issues and challenges against their prevention.

Authors:  Amos Olufemi Adeleye; Magbagbeola D Dairo; Kayode G Olowookere
Journal:  Childs Nerv Syst       Date:  2010-01-21       Impact factor: 1.475

10.  Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child.

Authors:  Régine P Steegers-Theunissen; Sylvia A Obermann-Borst; Dennis Kremer; Jan Lindemans; Cissy Siebel; Eric A Steegers; P Eline Slagboom; Bastiaan T Heijmans
Journal:  PLoS One       Date:  2009-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.